Cargando…
2275. Novel Therapeutic Options for the Treatment of Multi-Drug-Resistant Achromobacter Respiratory Infections
BACKGROUND: Respiratory infection due to Achromobacter species has been increasingly more common, especially in patients with cystic fibrosis (CF). Recurrent infections in these patients contribute to significant morbidity and mortality as well as lead to repeated antibiotic exposures with subsequen...
Autores principales: | Canonica, Theora, Thompson, Shruti, Carr, Amy, Alexander, Jose, Minor, Sarah Brooks |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809504/ http://dx.doi.org/10.1093/ofid/ofz360.1953 |
Ejemplares similares
-
2275. No "One-Size-Fits All": Chronic "Carryover" Diagnoses Dilute Antibiotic Prescribing Metrics in Primary Care
por: Smith, Mary, et al.
Publicado: (2023) -
2275. Parental Risk Factors for Fever in their Children 7–10 Days After the First Dose of Measles-Containing Vaccines
por: Zerbo, Ousseny, et al.
Publicado: (2018) -
1607. Dual Therapy with Aztreonam & Ceftazidime/Avibactam Against Multi-Drug Resistant Stenotrophomonas maltophilia on Tricuspid Valve Endocarditis
por: Alexander, Jose, et al.
Publicado: (2020) -
Inhaled Bacteriophage Therapy for Multi-Drug Resistant
Achromobacter
por: Winzig, Franziska, et al.
Publicado: (2022) -
Compounding Achromobacter Phages for Therapeutic Applications
por: Cobián Güemes, Ana Georgina, et al.
Publicado: (2023)